APR 05, 2017 7:15 AM PDT

Optimizing homology-directed repair (HDR) results with CRISPR-Cas9

Speaker
  • Research Scientist at Dharmacon, part of GE Healthcare
    Biography
      John Schiel is a research scientist at Dharmacon, part of GE Healthcare. He joined the R&D team at Dharmacon in 2014 and is actively involved in developing research tools within the gene modulation and genome editing fields of research which include RNA interference (http://dharmacon.gelifesciences.com/rnai-and-custom-rna-synthesis/) and CRISPR-Cas9 genome engineering (http://dharmacon.gelifesciences.com/gene-editing/crispr-cas9/) He received his Bachelor of Science degree in Biochemistry at Colorado State University and his Ph.D. degree in Cell Biology at the University of Colorado Denver - Anschutz Medical Campus. John completed a postdoctoral fellowship at University of Massachusetts Medical School where he studied asymmetric cell division and centrosome maturation.

    Abstract

    CRISPR-Cas9 has increased the accessibility of genome engineering due to its ease of use and ability to cause double strand breaks (DSBs) at almost any locus of interest. DSBs are repaired in cells by two predominant pathways: non-homologous end joining (NHEJ) and homology-directed repair (HDR). Endogenous repair of DSBs using the NHEJ pathway typically results in functional protein disruption (knockout) whereas the HDR pathway can be used to introduce exogenous genetic content (knockin). During this webinar we will focus on the utility of a synthetic dual RNA approach to apply CRISPR-Cas9 to HDR genomic engineering applications and will provide guidelines for improving CRISPR Cas9-assisted HDR. We will also discuss the use of short single-stranded DNA as a donor template for small insertions as well as plasmid DNA donor templates for large insertions. Lastly, we outline methods for characterization of HDR-generated cell lines for precise genomic engineering.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    NOV 10, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 10, 2020 7:00 AM PST
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    APR 05, 2017 7:15 AM PDT

    Optimizing homology-directed repair (HDR) results with CRISPR-Cas9


    Specialty

    Cell Biology

    Molecular Biology

    Cancer Research

    Biotechnology

    Cell Culture

    Gene Expression

    Genetics

    Immunology

    Crispr-Cas9

    Biomarkers

    Biochemistry

    Gene Editing

    Cancer Therapeutics

    Molecular Diagnostics

    Pcr/rt-Pcr/real-Time Pcr

    Geography

    North America53%

    Europe25%

    Asia13%

    South America4%

    Oceania3%

    Africa2%

    Registration Source

    Website Visitors100%

    Job Title

    Research Scientist21%

    Scientist17%

    Student16%

    Post Doc12%

    Educator/Faculty8%

    Executive8%

    Medical Doctor/Specialist6%

    Facility/Department Manager5%

    Medical Laboratory Technician2%

    Consultant1%

    Engineer1%

    Biologist1%

    Marketing/Sales1%

    Organization

    Academic Institution12%

    Biotech Company6%

    Research Institute6%

    Ambulatory Care4%

    Medical School4%

    Life Science Company2%

    Pharmaceutical Company2%

    Hospital2%

    Non-Profit Organization1%

    Medical Center1%

    Government1%

    Consultant1%

    Clinical Laboratory1%

    Industrial Company1%

    Other3%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more